Martín E. Stryjewski

Author

Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno ORCID

Also Known As

Daniel Sexton, Flavia L. Cilenti, M E Stryjewski, M. E. Stryjewski, M. Stryjewski, M.E. Stryjewski, ME Stryjewski, Martin E Stryjewski, Martin E. Stryjewski, Martin Stryjewski

138

Publications

Citations

H-Index

Concepts

All Affiliations

Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno Duke Medical Center Clinical Research Institute Duke University Theravance Biopharma (United States)

About

Martín E. Stryjewski is an author at Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	2.5K
2	Health Sciences	6	7	1K
3	Public Health	4	4	613
4	Emergency Medicine	3	3	329
5	Cell Biology	1	1	75

Martín E. Stryjewski

Publications

Citations

H-Index

Page 1

	Year	Citations
Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999 Christopher H. Cabell, Paul A. Heidenreich, Vivian H. Chu, American Heart Journal Health PolicyCardiac Device InfectionsHealthcare-associated InfectionHealth InsuranceHealth Care Cost	2004	396
Persistent Bacteremia Due to Methicillin‐Resistant<i>Staphylococcus aureus</i>Infection Is Associated with<i>agr</i>Dysfunction and Low‐Level In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal Protein Vance G. Fowler, George Sakoulas, Lauren M. McIntyre, The Journal of Infectious Diseases	2004	349
Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia Martín E. Stryjewski, Lynda A. Szczech, Danny Benjamin, Clinical Infectious Diseases	2006	342
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study Minggui Wang, Michelle Earley, Liang Chen, The Lancet Infectious Diseases Different Global RegionsAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	2021	308
Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms Martín E. Stryjewski, Donald R. Graham, Samuel E. Wilson, Clinical Infectious Diseases	2008	288
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study Jinnethe Reyes, Lauren Komarow, Liang Chen, The Lancet Microbe	2023	255
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens Eric Rubinstein, Tahaniyat Lalani, G. Ralph Corey, Clinical Infectious Diseases	2010	246
Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-Susceptible<i>Staphylococcus aureus</i>Bacteremia Shelby D. Reed, Joëlle Y. Friedman, John J. Engemann, Infection Control and Hospital Epidemiology	2005	199
Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis Lawrence P. Park, Vivian H. Chu, Gail Peterson, Journal of the American Heart Association	2016	199
Emergence of Coagulase-Negative Staphylococci as a Cause of Native Valve Endocarditis Vivian H. Chu, Christopher W. Woods, José M. Miró, Clinical Infectious Diseases	2007	194

Page 1